Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

REPH

Recro Pharma (REPH)

Recro Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:REPH
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202322h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/06/202322h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
26/05/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
22/05/202323h11Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
19/05/202322h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202322h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202322h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202322h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202322h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202322h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
18/05/202323h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
10/05/202322h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/05/202322h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
06/04/202314h26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
24/03/202321h07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
24/03/202321h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
13/03/202312h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
01/03/202323h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
01/03/202322h58Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
01/03/202322h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
01/03/202322h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
14/02/202320h58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
10/02/202315h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/02/202323h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
20/01/202322h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/01/202322h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
05/01/202322h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
03/01/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
20/12/202222h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
16/12/202223h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPHRecro Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:REPH